Medical-grade treatments are leaving the clinic.
What’s happening: Altro Health added $7M to scale its “Shopify for wellness businesses,” enabling clubs to offer peptides, GLP-1s, and hormone therapy in-house.
Inside job. Whitelabeling medical services, Altro streamlines the clinical supply chain, connecting trusted providers, prescription treatments, and personalized care.
Already partnering with 500 fitness operators, medspas, and longevity clubs, its plug-in infrastructure becomes a valuable unlock for the gym-as-clinic, bringing testing, training, and treatment together.
Open door. As regulatory changes widen access, DTC providers formalize treatment, and consumers explore everyday use cases, peptides are evolving from self-prescription and gray-market suppliers toward safer, precision pathways.
Building the guardrails, platforms like Protocole and System are building peptide stacks with tighter supply chains, while Daxko outsources clinical oversight for GLP-1s.
Punchline: Seeking to become the operating layer behind longevity’s $47B market, Altro wants to reshape the route to all injectables, turning local third places into authorized access points.
